TARSUS PHARMACEUTICALS INC (TARS) Stock Analyst Earnings Estimates
NASDAQ:TARS - Nasdaq - US87650L1035 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 57.03M | 25.82M -54.73% | 17.447M -32.43% | 178.29M 921.89% | 332.08M 86.26% | 508.84M 53.23% | 722.79M 42.05% | 848.78M 17.43% | 984.69M 16.01% | 1.052B 6.84% | 1.244B 18.25% | 1.321B 6.19% | |
| EBITDA YoY % growth | -11.85M 55.95% | -62.38M -426.41% | -142.281M -128.09% | -128.675M 9.56% | -75.278M 41.50% | 40.717M 154.09% | 86.873M 113.36% | 91.912M 5.80% | 92.381M 0.51% | 92.84M 0.50% | N/A | N/A | |
| EBIT YoY % growth | -12.16M 54.96% | -62.71M -415.71% | -143.158M -128.29% | -128.816M 10.02% | -79.832M 38.03% | 90.83M 213.78% | 306.21M 237.12% | 410.82M 34.16% | 530.88M 29.22% | 587.16M 10.60% | 810.49M 38.04% | 881.69M 8.78% | |
| Operating Margin | -21.32% | -242.87% | -820.53% | -72.25% | -24.04% | 17.85% | 42.37% | 48.40% | 53.91% | 55.81% | 65.15% | 66.74% | |
| EPS YoY % growth | -0.68 70.66% | -2.55 -275.00% | -4.64 -81.96% | -3.28 29.25% | -1.91 41.79% | 1.98 203.81% | -0.45 -122.62% | 1.91 525.00% | 2.62 37.43% | 2.45 -6.61% | N/A | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.61 39.83% | -0.59 33.06% | -0.59 2.79% | -0.15 74.23% | 0.42 168.81% | 0.62 205.63% | 0.82 237.62% | 1.12 825.59% |
| Revenue Q2Q % growth | 66.765M 141.78% | 75.439M 84.84% | 84.331M 75.26% | 92.437M 39.19% | 123.62M 85.16% | 132.39M 75.49% | 146.74M 74.00% | 163.79M 77.19% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.96M 41.73% | -23.507M 29.41% | -25.421M -1.03% | -7.807M 74.92% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.60 54.20% | -0.76 | 0.16 | 20.78% |
| Q3 2024 Q2Q % growth | -0.61 52.34% | -0.99 | 0.38 | 38.50% |
| Q2 2024 Q2Q % growth | -0.88 24.79% | -0.94 | 0.06 | 6.62% |
| Q1 2024 Q2Q % growth | -1.01 -14.77% | -1.23 | 0.22 | 17.81% |
| Q4 2023 Q2Q % growth | -1.31 -167.35% | -1.39 | 0.08 | 5.75% |
| Q3 2023 Q2Q % growth | -1.28 -52.38% | -1.39 | 0.11 | 8.10% |
| Q2 2023 Q2Q % growth | -1.17 -387.50% | -1.10 | -0.07 | -6.36% |
| Q1 2023 Q2Q % growth | -0.88 10.20% | -0.96 | 0.08 | 8.70% |
| Q4 2022 Q2Q % growth | -0.49 31.94% | -0.70 | 0.21 | 30.38% |
| Q3 2022 Q2Q % growth | -0.84 -10.53% | -0.99 | 0.15 | 15.35% |
| Q2 2022 Q2Q % growth | -0.24 -172.73% | -0.60 | 0.36 | 60.15% |
| Q1 2022 Q2Q % growth | -0.98 -308.51% | -0.94 | -0.04 | -4.68% |
| Q4 2021 Q2Q % growth | -0.72 -5.88% | -0.74 | 0.02 | 2.98% |
| Q3 2021 Q2Q % growth | -0.76 79.51% | -0.44 | -0.32 | -71.68% |
| Q2 2021 Q2Q % growth | 0.33 | -0.49 | 0.82 | 167.87% |
| Q1 2021 Q2Q % growth | 0.47 | -0.65 | 1.12 | 172.00% |
| Q4 2020 Q2Q % growth | -0.68 | -0.67 | -0.01 | -1.01% |
| Q3 2020 Q2Q % growth | -3.71 | -0.54 | -3.17 | -586.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 66.41M 407.88% | 59.494M | 6.916M | 11.62% |
| Q3 2024 Q2Q % growth | 48.118M 2,471.78% | 44.306M | 3.812M | 8.60% |
| Q2 2024 Q2Q % growth | 40.813M | 32.297M | 8.516M | 26.37% |
| Q1 2024 Q2Q % growth | 27.614M 1,004.56% | 17.805M | 9.809M | 55.09% |
| Q4 2023 Q2Q % growth | 13.076M 30.76% | 5.778M | 7.298M | 126.31% |
| Q3 2023 Q2Q % growth | 1.871M | 407.796K | 1.463M | 358.81% |
| Q2 2023 Q2Q % growth | -100.00% | 1.795M | -1.795M | -100.00% |
| Q1 2023 Q2Q % growth | 2.5M 362.96% | 3.188M | -688K | -21.58% |
| Q4 2022 Q2Q % growth | 10M 2,841.18% | 10.2M | -200K | -1.96% |
| Q3 2022 Q2Q % growth | -100.00% | 2.975M | -2.975M | -100.00% |
| Q2 2022 Q2Q % growth | 15.28M -30.61% | 13.26M | 2.02M | 15.23% |
| Q1 2022 Q2Q % growth | 540K -98.38% | 2.244M | -1.704M | -75.94% |
| Q4 2021 Q2Q % growth | 340K | 6.204M | -5.864M | -94.52% |
| Q3 2021 Q2Q % growth | 1.24M | 5.44M | -4.2M | -77.21% |
| Q2 2021 Q2Q % growth | 22.02M | 4.624M | 17.396M | 376.21% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.02% | 15.44% | 0.72% | 15.25% |
| Revenue | 2.6% | 29.79% | 0.39% | 7.27% |